Angiotensin II type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production

Journal of Interferon and Cytokine Research

Volumn 31, Issue 6, 2011, Pages 471-474

  Abadir, Peter M ^a   Walston, Jeremy D ^a   Carey, Robert M ^b   Siragy, Helmy M ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; IMIDAZOLES; IMMUNOMODULATION; INFLAMMATION; OLIGOPEPTIDES; PHOSPHORYLATION; PYRIDINES; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79958181700     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2010.0043     Document Type: Article

References (34)

1. Barber MN, Sampey DB, Widdop RE. 1999. AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension 34(5):1112-1116.
2. Bascands JL, Girolami JP, Troly M, Escargueil-Blanc I, Nazzal D, Salvayre R, Blaes N. 2001. Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells. Hypertension 38(6):1294-1299. (Pubitemid 34033405)
3. Beasley D. 1997. Phorbol ester and interleukin-1 induce interleukin-6 gene expression in vascular smooth muscle cells via independent pathways. J Cardiovasc Pharmacol 29(3): 323-330. (Pubitemid 27194717)
4. Carey RM, Howell NL, Jin XH, Siragy HM. 2001. Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension 38(6):1272-1277. (Pubitemid 34033401)
5. Carey RM, Siragy HM. 2003. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 24(3):261-271. (Pubitemid 36733542)
6. Chappell VL, Le LX, LaGrone L, Mileski WJ. 2000. Stat proteins play a role in tumor necrosis factor alpha gene expression. Shock 14(3):400-402; discussion 402-403.
7. Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, de Cesare D, Ucchino S, Spigonardo F, De Luca M, and others. 2004. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation 109(12):1482-1488. (Pubitemid 38420175)
8. Costantino L, Barlocco D. 2008. STAT 3 as a target for cancer drug discovery. Curr Med Chem 15(9):834-843. (Pubitemid 351736406)
9. De Paolis P, Porcellini A, Gigante B, Giliberti R, Lombardi A, Savoia C, Rubattu S, Volpe M. 1999. Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells. J Hypertens 17(12 Pt 2):1873-1877. (Pubitemid 30345325)
10. Ershler WB, Keller ET. 2000. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245-270. (Pubitemid 30216036)
11. Fujita J, Tsujinaka T, Ebisui C, Yano M, Shiozaki H, Katsume A, Ohsugi Y, Monden M. 1996. Role of interleukin-6 in skeletal muscle protein breakdown and cathepsin activity in vivo. Eur Surg Res 28(5):361-366. (Pubitemid 26305849)
12. Guan H, Cachofeiro V, Pucci ML, Kaminski PM, Wolin MS, Nasjletti A. 1996. Nitric oxide and the depressor response to angiotensin blockade in hypertension. Hypertension 27(1): 19-24. (Pubitemid 26020665)
13. Guo D, Dunbar JD, Yang CH, Pfeffer LM, Donner DB. 1998. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J Immunol 160(6):2742-2750. (Pubitemid 28136727)
14. Hahn AW, Jonas U, Buhler FR, Resink TJ. 1994. Activation of human peripheral monocytes by angiotensin II. FEBS Lett 347(2-3):178-180. (Pubitemid 24215389)
15. Han Y, Runge MS, Brasier AR. 1999. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 84(6):695-703. (Pubitemid 29157337)
16. Maggio M, Guralnik JM, Longo DL, Ferrucci L. 2006. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 61(6):575-584.
17. Matsubara H. 1998. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83(12):1182-1191. (Pubitemid 29006033)
18. Mills JD, Stone JR, Rubin DG, Melon DE, Okonkwo DO, Peria-samy A, Helm GA. 2003. Illuminating protein interactions in tissue using confocal and two-photon excitation fluorescent resonance energy transfer microscopy. J Biomed Opt 8(3): 347-356.
19. Miscia S, Marchisio M, Grilli A, Di Valerio V, Centurione L, Sabatino G, Garaci F, Zauli G, Bonvini E, Di Baldassarre A. 2002. Tumor necrosis factor alpha (TNF-alpha) activates Jak1/ Stat3-Stat5B signaling through TNFR-1 in human B cells. Cell Growth Differ 13(1):13-18. (Pubitemid 34106795)
20. Nickenig G, Harrison DG. 2002. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxida-tive stress and atherogenesis. Circulation 105(3):393-396. (Pubitemid 34106191)
21. Oishi Y, Ozono R, Yoshizumi M, Akishita M, Horiuchi M, Oshima T. 2006. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling. Life Sci 80(1):82-88. (Pubitemid 44809300)
22. Omura T, Yoshiyama M, Takeuchi K, Kim S, Iwao H, Yamagishi H, Toda I, Teragaki M, Akioka K, Yoshikawa J. 2000. Angio-tensin blockade inhibits SIF DNA binding activities via STAT3 after myocardial infarction. J Mol Cell Cardiol 32(1):23-33. (Pubitemid 30064301)
23. Ozono R, Matsumoto T, Shingu T, Oshima T, Teranishi Y, Kambe M, Matsuura H, Kajiyama G, Wang ZQ, Moore AF, and others. 2000. Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart. Am J Physiol Regul Integr Comp Physiol 278(3):R781-R789. (Pubitemid 30158141)
24. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM. 1997. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30(5):1238-1246. (Pubitemid 27476185)
25. Shibata K, Makino I, Shibaguchi H, Niwa M, Katsuragi T, Fur-ukawa T. 1997. Up-regulation of angiotensin type 2 receptor mRNA by angiotensin II in rat cortical cells. Biochem Biophys Res Commun 239(2):633-637. (Pubitemid 27489017)
26. Siragy HM, Awad A, Abadir P, Webb R. 2003. The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats. Endocrinology 144(6): 2229-2233. (Pubitemid 36629871)
27. Siragy HM, Carey RM. 1999. Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 33(5):1237-1242. (Pubitemid 29230980)
28. Siragy HM, de Gasparo M, Carey RM. 2000. Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension 35(5):1074-1077. (Pubitemid 30327260)
29. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. 2003. Inflammation and angiotensin II. Int J Biochem Cell Biol 35(6):881-900. (Pubitemid 36379329)
30. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, and others. 2000. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure. J Am Coll Cardiol 35(3):714-721. (Pubitemid 30167029)
31. Wang ZQ, Moore AF, Ozono R, Siragy HM, Carey RM. 1998. Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart. Hypertension 32(1):78-83. (Pubitemid 28324128)
32. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, and others. 1999. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99(15):2027-2033. (Pubitemid 29183901)
33. Weber MA. 1992. Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report. Am J Hypertens 5(12 Pt 2):247S-251S. (Pubitemid 23076901)
34. Zahradka P, Yau L, Lalonde C, Buchko J, Thomas S, Werner J, Nguyen M, Saward L. 1998. Modulation of the vascular smooth muscle angiotensin subtype 2 (AT2) receptor by an-giotensin II. Biochem Biophys Res Commun 252(2):476-80. (Pubitemid 28542912)